Valsartan-mediated chronotherapy in spontaneously hypertensive rats via targeting clock gene expression in vascular smooth muscle cells

References

• Calvo, C., 2004. Prevalence of non-dipper blood pressure pattern in elderly patients with essential hypertension as a function of circadian time of antihypertensive treatment. American journal of hypertension, 17 (5), S43–S44.
   PubMed Web of Science ®Google Scholar
• Chen, S., et al., 2014. Hyperlipidaemia impairs the circadian clock and physiological homeostasis of vascular smooth muscle cells via the suppression of Smarcd1. The journal of pathology, 233 (2), 159–169.
   PubMed Web of Science ®Google Scholar
• Curtis, A.M., et al., 2007. Circadian variation of blood pressure and the vascular response to asynchronous stress. Proceedings of the national academy of sciences of sciences, 104 (9), 3450–3455.
   PubMed Web of Science ®Google Scholar
• Curtis, A.M., et al., 2014. Circadian clock proteins and immunity. Immunity, 40 (2), 178–186.
   PubMed Web of Science ®Google Scholar
• Dallmann, R., et al., 2016. Dosing-time makes the poison: circadian regulation and pharmacotherapy. Trends in molecular medicine, 22 (5), 430–445.
   PubMed Web of Science ®Google Scholar
• Douma, L.G., et al., 2018. Circadian clock-mediated regulation of blood pressure. Free radical biology and medicine, 119, 108–114.
   PubMed Web of Science ®Google Scholar
• Douma, L.G., et al., 2019. Female C57BL/6J mice lacking the circadian clock protein PER1 are protected from nondipping hypertension. American journal of physiology. Regulatory, integrative and comparative physiology, 316 (1), 50–58.
   Web of Science ®Google Scholar
• Enoki, R., et al., 2017. Dual origins of the intracellular circadian calcium rhythm in the suprachiasmatic nucleus. Scientific reports, 7 (1), 41733.
   PubMedGoogle Scholar
• Gorostidi, M., et al., 2007. Ambulatory blood pressure monitoring in hypertensive patients with high cardiovascular risk: a cross-sectional analysis of a 20,000-patient database in Spain. Journal of hypertension, 25 (5), 977–984.
   PubMed Web of Science ®Google Scholar
• Griggs, C.A., et al., 2018. Valproic acid disrupts the oscillatory expression of core circadian rhythm transcription factors. Toxicology and applied pharmacology, 339, 110–120.
   PubMed Web of Science ®Google Scholar
• Hermida, R.C., et al., 2018. Hypertension: new perspective on its definition and clinical management by bedtime therapy substantially reduces cardiovascular disease risk. European journal of clinical investigation, 48 (5), e12909–e12921.
   PubMed Web of Science ®Google Scholar
• Higashi, Y., et al., 2002. Circadian variation of blood pressure and endothelial function in patients with essential hypertension: a comparison of dippers and non-dippers. Journal of the American college of cardiology, 40 (11), 2039–2043.
   PubMed Web of Science ®Google Scholar
• Hou, T., et al., 2019. A novel diabetic mouse model for real-time monitoring of clock gene oscillation and blood pressure circadian rhythm. Journal of biological rhythms, 34 (1), 51–68.
   PubMed Web of Science ®Google Scholar
• Hughes, M., et al., 2010. JTK_CYCLE: an efficient non-parametric algorithm for detecting rhythmic components in genome-scale datasets. Journal of biological rhythms, 25 (5), 372–380.
   PubMed Web of Science ®Google Scholar
• Kario, K., et al., 2003. Morning surge in blood pressure as a predictor of silent and clinical cerebrovascular disease in elderly hypertensives: a prospective study. Circulation, 108 (10), 72–73.
   Web of Science ®Google Scholar
• Kim, M.W., et al., 2007. Lack of correlation between QTc dispersion and morning blood pressure surge in recently diagnosed essential hypertensive patients. Circulation journal, 71 (8), 1288–1292.
   PubMed Web of Science ®Google Scholar
• Lee, I.T., et al., 2015. Neuromedin s-producing neurons act as essential pacemakers in the suprachiasmatic nucleus to couple clock neurons and dictate circadian rhythms. Neuron, 85 (5), 1086–1102.
   PubMed Web of Science ®Google Scholar
• Lin, C., et al., 2014. The rhythmic expression of clock genes attenuated in human plaque-derived vascular smooth muscle cells. Lipids in health and disease, 13 (1), 14–23.
   PubMedGoogle Scholar
• Lin, C., et al., 2017. Intracellular high cholesterol content disorders the clock genes, apoptosis-related genes and fibrinolytic-related genes rhythmic expressions in human plaque-derived vascular smooth muscle cells. Lipids in health and disease, 16 (1), 135–143.
   PubMedGoogle Scholar
• Liu, C., et al., 2018. Bmal1 in perivascular adipose tissue regulates resting-phase blood pressure through transcriptional regulation of angiotensinogen. Circulation, 138 (1), 67–79.
   PubMed Web of Science ®Google Scholar
• Martino, T.A., et al., 2015. Influence of the cardiomyocyte circadian clock on cardiac physiology and pathophysiology. Journal of biological rhythms, 30 (3), 183–205.
   PubMed Web of Science ®Google Scholar
• Moniwa, N., et al., 2012. Restoration of the blood pressure circadian rhythm by direct renin inhibition and blockade of angiotensin II receptors in mRen2.Lewis hypertensive rats. Therapeutic advances in cardiovascular disease, 6 (1), 15–29.
   PubMedGoogle Scholar
• Naito, Y., et al., 2003. Circadian gene expression of clock genes and plasminogen activator inhibitor-1 in heart and aorta of spontaneously hypertensive and Wistar-Kyoto rats. Journal of hypertension, 21 (6), 1107–1115.
   PubMed Web of Science ®Google Scholar
• Nonaka, H., et al., 2001. Angiotensin II induces circadian gene expression of clock genes in cultured vascular smooth muscle cells. Circulation, 104 (15), 1746–1748.
   PubMed Web of Science ®Google Scholar
• Potucek, P., et al., 2017. mRNA levels of circadian clock components Bmal1 and Per2 alter independently from dosing time-dependent efficacy of combination treatment with valsartan and amlodipine in spontaneously hypertensive rats. Clinical and experimental hypertension, 39 (8), 754–763.
   PubMed Web of Science ®Google Scholar
• Rahman, A., et al., 2017. Cardioprotective effects of SGLT2 inhibitors are possibly associated with normalization of the circadian rhythm of blood pressure. Hypertension research, 40 (6), 535–540.
   PubMed Web of Science ®Google Scholar
• Rahman, A., et al., 2018. Altered circadian timing system-mediated non-dipping pattern of blood pressure and associated cardiovascular disorders in metabolic and kidney diseases. International journal of molecular sciences, 19 (2), 400–421.
   Web of Science ®Google Scholar
• Rodrigo, G.C., et al., 2018. Regulation of vascular function and blood pressure by circadian variation in redox signalling. Free radical biology and medicine, 119, 115–120.
   PubMed Web of Science ®Google Scholar
• Ruan, G.X., et al., 2012. Divergent roles of clock genes in retinal and suprachiasmatic nucleus circadian oscillators. PLoS One, 7 (6), e38985.
   PubMed Web of Science ®Google Scholar
• Sei, H., et al., 2008. Diurnal amplitudes of arterial pressure and heart rate are dampened in Clock mutant mice and adrenalectomized mice. Endocrinology, 149 (7), 3576–3580.
   PubMed Web of Science ®Google Scholar
• Smolensky, M.H., et al., 2016. Circadian disruption: new clinical perspective of disease pathology and basis for chronotherapeutic intervention. Chronobiology international, 33 (8), 1101–1119.
   PubMed Web of Science ®Google Scholar
• Soylu, A., et al., 2009. Relation between abnormalities in circadian blood pressure rhythm and target organ damage in normotensives. Circulation journal, 73 (5), 899–904.
   PubMed Web of Science ®Google Scholar
• Su, W., et al., 2012. Altered clock gene expression and vascular smooth muscle diurnal contractile variations in type 2 diabetic db/db mice. American journal of physiology. heart and circulatory physiology, 302 (3), 621–633.
   PubMed Web of Science ®Google Scholar
• Sulli, G., et al., 2018. Training the circadian clock, clocking the drugs, and drugging the clock to prevent, manage, and treat chronic diseases. Trends in pharmacological sciences, 39 (9), 812–827.
   PubMed Web of Science ®Google Scholar
• Thomas, M.A., et al., 2004. Localization of components of the renin-angiotensin system in the suprachiasmatic nucleus of normotensive Sprague–Dawley rats: part B. Angiotensin II (AT1)-receptors, a light and electron microscopic study. Brain research, 1008 (2), 224–235.
   PubMed Web of Science ®Google Scholar
• Ushijima, K., et al., 2015. Different chronotherapeutic effects of valsartan and olmesartan in non-dipper hypertensive patients during valsartan treatment at morning. Journal of pharmacological sciences, 127 (1), 62–68.
   PubMed Web of Science ®Google Scholar
• Verdecchia, P., et al., 1990. Circadian blood pressure changes and left ventricular hypertrophy in essential hypertension. Circulation, 81 (2), 528–536.
   PubMed Web of Science ®Google Scholar
• Vukolic, A., et al., 2010. Role of mutation of the circadian clock gene Per2 in cardiovascular circadian rhythms. American journal of physiology. Regulatory, integrative and comparative physiology, 298 (3), 627–634.
   Web of Science ®Google Scholar
• Wang, R., et al., 2019. RNA-sequencing analysis reveals l-theanine regulating transcriptional rhythm alteration in vascular smooth muscle cells induced by dexamethasone. Journal of agricultural and food chemistry, 67 (19), 5413–5422.
   PubMed Web of Science ®Google Scholar
• Xie, Z., et al., 2015. Smooth-muscle BMAL1 participates in blood pressure circadian rhythm regulation. Journal of clinical investigation, 125 (1), 324–336.
   PubMed Web of Science ®Google Scholar
• Yang, K., et al., 2019. Valsartan chronotherapy reverts the non-dipper pattern and improves blood pressure control through mediation of circadian rhythms of the renin-angiotensin system in spontaneous hypertension rats. Chronobiology international, 36 (8), 1058–1071.
   PubMed Web of Science ®Google Scholar
• Zhou, D., et al., 2016. Evolving roles of circadian rhythms in liver homeostasis and pathology. Oncotarget, 7 (8), 8625–8639.
   PubMedGoogle Scholar